A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Latest Reports Latest NewsOver 500 Clients, Large & Small from Around the World, Have Trusted Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 295
Comprehensive Pages
- 5
Year Market Forecasts
- 21
Competitor Profiles
- 8
Geographic and Economic Breakouts
2022 Refractive Surgery Market Report: Global Analysis for 2021 to 2027, December, 2022
The “2022 Refractive Surgery Market Report” analyzes the global refractive and presbyopia-correcting market, identifying important trends and key factors for future success. It focuses on the 2022 refractive and presbyopia-correcting surgical market and forecasts market growth and evolution over the next five years. Included are discussions and market estimates for LASIK, lenticular extraction, phakic IOLs, refractive lens exchange (RLE), and other technologies that may disrupt the market.
Latest Industry News & Trends
9/22/2023
BreakingClinical TrialPharmaRetina
Two-Year Results for Izervay Show Continued Slowing of GA Growth
Iveric Bio, an Astellas company, reported on Sept. 18 positive 24-month topline results from the Phase III GATHER2 trial of Izervay (avacincaptad pegol), its treatment for geographic atrophy (GA) s...
9/22/2023
BreakingCataractDry EyeGlaucomaIndustryPharma
Mati Completes Facility to Manufacture Evolute Punctal Plug Portfolio
Mati Therapeutics, of Austin, Texas, reported Sept. 12 that it had completed a 10 thousand square foot facility in Bryan, Texas, to manufacture the company’s Evolute sustained drug delivery platfor...
9/22/2023
BreakingDealsPharma
Novartis Readies Spinout of Sandoz, a Leading Provider of Generic Ophthalmic Drugs
Swiss company Novartis reported Sept. 15 that its shareholders had approved its spinoff of Sandoz, its generics and biosimilars business. The target date for the spinoff is Oct. 4. Sandoz is a lead...
9/21/2023
CataractEnvironmentMeetingNewsletter
2023 ESCRS Congress Pits Greener Choices Against Traditional Practices to Fight Waste
Eye surgeons swapped their scrubs for boxing robes at the 2023 congress of the European Society of Cataract and Refractive Surgeons, as they took part in the society’s high-profile battle against s...
9/22/2023
BreakingDiagnosticRetina
US FDA Clears Expanded FA Capabilities of NeoLight’s Portable Retinal Camera Icon Go
NeoLight announced Sept. 12 that the US FDA had cleared the expanded fluorescein angiography (FA) capabilities of the company’s portable retinal camera Icon Go. The Scottsdale, Arizona, company sai...
9/22/2023
BreakingPharma
Precision Dropper Aims for Greater Patient Comfort, Less Waste
Precision Dropper, of Twin Falls, Idaho, on Sept. 15 introduced its universal adapter for eye drop bottles, designed to increase patient comfort and reduce waste when administering topical ocular m...
9/22/2023
BreakingGene TherapyIndustryRetina
Nanoscope Appoints Samuel Barone, MD, as Chief Medical Officer
Nanoscope Therapeutics, of Dallas, announced Sept. 21 that it had appointed Samuel Barone, MD, as chief medical officer. Barone was most recently chief medical officer at Gemini Therapeutics, prior...
9/21/2023
EarningsNewsletterRetinaRevenue
Ophthalmic Company Revenue in Q2-2023 Rises 1.5 Percent
Ophthalmic manufacturer revenue in Q2-2023 totaled $11.4 billion. Most public companies reported above-average revenue in Q2-2023 compared with the past three years, while four public companies had...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.